Published in Mayo Clin Proc on April 01, 1991
Outcome of selective ramisectomy for botulinum toxin resistant torticollis. J Neurol Neurosurg Psychiatry (1998) 1.52
Symptomatic and functional outcome of surgical treatment of cervical dystonia. J Neurol Neurosurg Psychiatry (1997) 0.99
Cervical Dystonia (Torticollis). Curr Treat Options Neurol (1999) 0.77
Spasmodic torticollis: the role of surgical denervation. Mayo Clin Proc (1991) 0.76
Treatment of spasmodic torticollis. Mayo Clin Proc (1991) 0.75
Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology (2007) 4.28
The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology (1993) 4.18
Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain (2007) 3.82
Epidemiology of cervical radiculopathy. A population-based study from Rochester, Minnesota, 1976 through 1990. Brain (1994) 3.07
The role of radiotracer imaging in Parkinson disease. Neurology (2005) 3.02
Superficial siderosis. Neurology (2006) 2.98
Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology (1999) 2.81
Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment. Mov Disord (1994) 2.77
Aversive properties of the negative stimulus in a successive discrimination. J Exp Anal Behav (1969) 2.75
Cognitive impairment after ECT in patients with Parkinson's disease and psychiatric illness. Am J Psychiatry (1992) 2.68
REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology (2010) 2.50
Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects. Neurology (1995) 2.42
Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study. Neurology (2000) 2.31
Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology (1997) 2.23
Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology (2007) 2.22
Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov Disord (2000) 2.20
Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study. Neurology (2009) 2.09
Lack of progression of neurologic deficit in survivors of paralytic polio: a 5-year prospective population-based study. Neurology (1996) 2.07
Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology (2003) 1.97
Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group. Neurology (1998) 1.92
Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol (1993) 1.91
Inclusion body myositis. Observations in 40 patients. Brain (1989) 1.82
Pseudotumor cerebri. Ann Intern Med (1982) 1.78
Neurologic manifestations in welders with pallidal MRI T1 hyperintensity. Neurology (2005) 1.75
Imaging correlates of pathology in corticobasal syndrome. Neurology (2010) 1.71
A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol (1994) 1.68
Medical records documentation of constipation preceding Parkinson disease: A case-control study. Neurology (2009) 1.64
Stereotactic ventrolateralis thalamotomy for medically refractory tremor in post-levodopa era Parkinson's disease patients. J Neurosurg (1991) 1.57
Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County project. Neurology (1993) 1.57
Head trauma preceding PD: a case-control study. Neurology (2003) 1.54
Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. J Neurol Neurosurg Psychiatry (1995) 1.47
The utility of magnetic stimulation for routine peripheral nerve conduction studies. Muscle Nerve (1988) 1.46
Autonomic involvement in extrapyramidal and cerebellar disorders. Clin Auton Res (1991) 1.44
Education and occupations preceding Parkinson disease: a population-based case-control study. Neurology (2005) 1.43
The clinical spectrum of critical illness polyneuropathy. Mayo Clin Proc (1994) 1.43
The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology (1991) 1.43
Validity of family history data on PD: evidence for a family information bias. Neurology (2003) 1.41
Far-field auditory brainstem response in neurotologic surgery. Am J Otol (1996) 1.40
The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity. Neurology (1992) 1.38
Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study. Mov Disord (2001) 1.35
Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med (2013) 1.31
Not 'indifference to pain' but varieties of hereditary sensory and autonomic neuropathy. Brain (1983) 1.29
Idiopathic intracranial hypertension. Mayo Clin Proc (1994) 1.28
Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy. Diabetes Care (1987) 1.27
Hereditary motor and sensory neuropathy with diaphragm and vocal cord paresis. Ann Neurol (1994) 1.26
Alpha-synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals. Neurology (2006) 1.24
Distinction between neoplastic and radiation-induced brachial plexopathy, with emphasis on the role of EMG. Neurology (1989) 1.22
The gene for HMSN2C maps to 12q23-24: a region of neuromuscular disorders. Neurology (2003) 1.22
Hemimasticatory spasm: clinical and electrophysiologic observations. Neurology (1992) 1.21
Parameters of anorectal and colonic motility in health and in severe constipation. Dis Colon Rectum (1993) 1.20
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials. J Neurol Sci (2001) 1.10
Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease. Sleep Med (2006) 1.10
Physiological prediction of muscle forces--I. Theoretical formulation. Neuroscience (1991) 1.09
Multicenter study of cabergoline, a long-acting dopamine receptor agonist, in Parkinson's disease patients with fluctuating responses to levodopa/carbidopa. Neurology (1993) 1.07
Randomized prospective trial comparing ileal pouch-anal anastomosis performed by excising the anal mucosa to ileal pouch-anal anastomosis performed by preserving the anal mucosa. Ann Surg (1997) 1.04
Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: a case-control study. Neurology (2006) 1.04
Transdiaphragmatic twitch pressure. Effects of lung volume and chest wall shape. Am Rev Respir Dis (1989) 1.02
Brain metal concentrations in chronic liver failure patients with pallidal T1 MRI hyperintensity. Neurology (2006) 1.01
Use of percentiles and normal deviates to express nerve conduction and other test abnormalities. Muscle Nerve (2001) 1.00
Effectiveness of ECT in patients with parkinsonism. J Neuropsychiatry Clin Neurosci (1998) 0.99
Movement disorders as sequelae of central pontine myelinolysis: report of three cases. Mov Disord (1992) 0.98
Focal shoulder-elevation dystonia. Mov Disord (2000) 0.95
Effect of BAEP monitoring on hearing preservation during acoustic neuroma resection. Neurology (1992) 0.95
Late effects of paralytic poliomyelitis in Olmsted County, Minnesota. Neurology (1991) 0.95
Clinical presentation and pharmacological therapy in corticobasal degeneration. Arch Neurol (1998) 0.95
Double-blind, placebo-controlled study of the application of capsaicin cream in chronic distal painful polyneuropathy. Pain (1995) 0.94
Effects of alterations in pulmonary function and sleep variables on survival in patients with amyotrophic lateral sclerosis. Mayo Clin Proc (1991) 0.94
Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies. Parkinsonism Relat Disord (2011) 0.94
Constrictive pericarditis and pleuropulmonary disease linked to ergot dopamine agonist therapy (cabergoline) for Parkinson's disease. Mayo Clin Proc (1999) 0.94
Utility of an EMG mapping study in treating cervical dystonia. Muscle Nerve (2000) 0.94
Brain metastasis in hypernephroma. J Neurooncol (1987) 0.93
Hereditary late-onset chorea without significant dementia: genetic evidence for substantial phenotypic variation in Huntington's disease. Neurology (1995) 0.93
Subacute diabetic proximal neuropathy. Mayo Clin Proc (1997) 0.93
Amantadine treatment is an independent predictor of improved survival in Parkinson's disease. Neurology (1996) 0.93
Dynamic joint forces during knee isokinetic exercise. Am J Sports Med (1991) 0.93
Myelin protein zero mutation His39Pro: hereditary motor and sensory neuropathy with variable onset, hearing loss, restless legs and multiple sclerosis. J Neurol Neurosurg Psychiatry (2006) 0.92
Neuropsychological profiles of manganese neurotoxicity. Eur J Neurol (2006) 0.92
Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology. Eur J Neurol (2013) 0.92
Drug-induced parkinsonism as a risk factor for Parkinson's disease: a historical cohort study in Olmsted County, Minnesota. Mayo Clin Proc (1998) 0.91
In-vivo function of the thumb muscles. Clin Biomech (Bristol, Avon) (1999) 0.90
Surgical therapy for tremor in multiple sclerosis: an evaluation of outcome measures. Neurology (2001) 0.88
The role of autonomic testing in the differentiation of Parkinson's disease from multiple system atrophy. J Neurol Sci (2012) 0.87
PHNO [(+)-4-propyl-9-hydroxynaphthoxazine]: a new and effective anti-Parkinson's disease agent. Neurology (1988) 0.87
Standard specification for transferring digital neurophysiological data between independent computer systems (ASTM E1467-92) J Clin Neurophysiol (1993) 0.86
Intraoperative electrophysiologic monitoring of laryngeal muscle during thyroid surgery. Laryngoscope (1988) 0.86
Novelty seeking and introversion do not predict the long-term risk of Parkinson disease. Neurology (2010) 0.84
Lewy bodies are not increased in progressive supranuclear palsy compared with normal controls. Neurology (2001) 0.84
Decreased catecholamines in the adrenal medulla of patients with parkinsonism. N Engl J Med (1988) 0.84
Computer-assisted stereotactic ventralis lateralis thalamotomy with microelectrode recording control in patients with Parkinson's disease. Mayo Clin Proc (1987) 0.83
Overeating and obesity from damage to a noradrenergic system in the brain. Science (1973) 0.83
Botulinum toxin injection for adductor spastic dysphonia: patient self-ratings of voice and phonatory effort after three successive injections. Laryngoscope (1993) 0.83
Parkinson's disease complicated by anxiety. Mayo Clin Proc (1987) 0.83
Somatosensory evoked potentials: clinical uses. AAEM Somatosensory Evoked Potentials Subcommittee. American Association of Electrodiagnostic Medicine. Muscle Nerve (1998) 0.82
Total shoulder arthroplasty in patients with Parkinson's disease. J Shoulder Elbow Surg (1997) 0.82
Uptake and retrograde transport of horseradish peroxidase in frog sartorius nerve in vitro. Brain Res (1973) 0.82
Autonomic failure in Guamanian neurodegenerative disease. Neurology (1997) 0.81
Electromyographic studies of the reconstructed lower eyelid after a modified Hughes procedure. Am J Ophthalmol (1995) 0.81
A limited role for DJ1 in Parkinson disease susceptibility. Neurology (2004) 0.80
Physiological prediction of muscle forces--II. Application to isokinetic exercise. Neuroscience (1991) 0.80